HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Gains from Investment Securities (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Gains from Investment Securities came in at $11.5 million in Q2 2021, up 63.64% year-over-year from $7.1 million in Q2 2020, and down 62.19% quarter-over-quarter from $30.5 million in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Gains from Investment Securities (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Gains from Investment Securities for 4 consecutive years, with $11.5 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Gains from Investment Securities rose 63.64% year-over-year to $11.5 million in Q2 2021; TTM through Jun 2021 was $77.4 million, a 70.86% increase from a year earlier, with the FY2025 full-year figure at $22.7 million, down 51.26% from the prior year.
  • Gains from Investment Securities was $11.5 million for Q2 2021 at HUTCHMED (China), down from $30.5 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $30.5 million in Q1 2021 and troughed at $1.1 million in Q2 2019.
  • A 4-year average of $14.1 million and a median of $11.6 million in 2018 frame the typical range for Gains from Investment Securities.
  • Across the five-year window, Gains from Investment Securities plunged 87.49% in 2019 and soared 563.31% in 2020, its largest moves.
  • Over 4 years, Gains from Investment Securities stood at $11.7 million in 2018, then fell by 14.8% to $10.0 million in 2019, then retreated by 29.22% to $7.1 million in 2020, then surged by 63.64% to $11.5 million in 2021.
  • The last three Gains from Investment Securities figures came in at $11.5 million (Q2 2021), $30.5 million (Q1 2021), and $7.1 million (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.37 Bn 197.38 Bn 7.24 Bn
2 Gilead Sciences 181.12 Bn 177.94 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.11 Bn 124.26 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn
5 Argenx Se 61.69 Bn 56.50 Bn 1.37 Bn
6 Moderna 54.62 Bn 49.48 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.14 Bn 30.84 Bn 992.69 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn
9 Roivant Sciences 30.09 Bn 30.09 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 11.54 Mn
Mar 31, 2021 30.51 Mn
Jun 30, 2020 7.05 Mn
Mar 31, 2020 28.27 Mn
Dec 31, 2019 9.96 Mn
Jun 30, 2019 1.06 Mn
Mar 31, 2019 17.11 Mn
Dec 31, 2018 11.69 Mn
Jun 30, 2018 8.50 Mn
Mar 31, 2018 15.03 Mn